+33 1 76 70 47 90
/
creativ@creativ-ceutical.com
Home
Who We Are
About Us
Strategic Management Board
What we do
Value & Market Access
Payer Landscape
Pricing Research
Early Dialog
PRMA Strategy
Evidence Generation
Decision Sciences & Outcomes Research
Modeling
HTA submission
Data Analytics
Evidence Synthesis
Patient-Centered Research
Real World Evidence
Exclusive Customized Consulting
Biotech Strategic Consulting
Corporate Strategic Consulting
Expertise
Senior Management
Partnerships
Japan
Publications
News & Events
Careers
Contact
Home
Who We Are
About Us
Strategic Management Board
What we do
Value & Market Access
Payer Landscape
Pricing Research
Early Dialog
PRMA Strategy
Evidence Generation
Decision Sciences & Outcomes Research
Modeling
HTA submission
Data Analytics
Evidence Synthesis
Patient-Centered Research
Real World Evidence
Exclusive Customized Consulting
Biotech Strategic Consulting
Corporate Strategic Consulting
Expertise
Senior Management
Partnerships
Japan
Publications
News & Events
Careers
Contact
Low rates of patient-reported outcome claims for orphan drugs approved by the us food and drug administration
Home
Publications
Low rates of patient-reported outcome claims for orphan drugs approved by the us food and drug administration
Back Home
Low rates of patient-reported outcome claims for orphan drugs approved by the us food and drug administration
2018 Journal of Market Access & Health Policy
Jarosławski, S. | Auquier, P. | Borissov, B. | Dussart, C. | Toumi, M. |
Volume: 6, Issue: 1, Pages: ,
The website uses cookies.
Learn More
Ok